719641001: Velpatasvir (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Velpatasvir (substance)
\Substance categorized by disposition\Substance with antiviral mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Velpatasvir (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Anti-infective agent (substance)\Substance with antiviral mechanism of action (substance)\Hepatitis C virus protein NS5A inhibitor\Velpatasvir (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Imidazole\Velpatasvir (substance)

\Organic compound\Substance with ether structure\Velpatasvir (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Imidazole\Velpatasvir (substance)
\Organic compound\Organic nitrogen compound\Azole\Imidazole\Velpatasvir (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3317222016 Velpatasvir (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3317223014 Velpatasvir en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

1881511000195116 velpatasvir it Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

849101000172110 velpatasvir fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Velpatasvir (substance)	Is a	Hepatitis C virus protein NS5A inhibitor	true	Inferred relationship	Some
Velpatasvir (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Hepatitis C virus protein NS5A inhibitor (disposition)	true	Inferred relationship	Some
Velpatasvir (substance)	Is a	Imidazole	true	Inferred relationship	Some
Velpatasvir (substance)	Is a	éther	false	Inferred relationship	Some
Velpatasvir (substance)	Is a	Substance with ether structure	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing sofosbuvir and velpatasvir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing sofosbuvir and velpatasvir and voxilaprevir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing sofosbuvir and velpatasvir and voxilaprevir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Sofosbuvir- and velpatasvir-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing only sofosbuvir and velpatasvir and voxilaprevir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing only sofosbuvir and velpatasvir (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing only sofosbuvir and velpatasvir and voxilaprevir in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Sofosbuvir and velpatasvir only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Velpatasvir-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Velpatasvir (substance)	Inferred relationship	Some	1
Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Velpatasvir (substance)	Inferred relationship	Some	2
Sofosbuvir 400 mg and velpatasvir 100 mg oral capsule	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Velpatasvir (substance)	Inferred relationship	Some	2
Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram and voxilaprevir 100 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Velpatasvir (substance)	Inferred relationship	Some	2

This concept is not in any reference sets